Rivian (NASDAQ:RIVN) stock is slipping on Wednesday after the company’s shares were hit with a downgrade from Deutsche Bank analysts.These analysts downgraded shares of RIVN stock from a “buy” rating to a “hold” rating today. For the record, the analysts’ consensus rating for RIVN shares is moderate buy.In addition to that downgrade, the Deutsche Bank analysts also dropped the price target for RIVN stock from $29 per share to $19 per share. That’s still a potential 6.6% increase over its prior closing price ...

The excitement around artificial intelligence that fueled the U.S. stock-market rally last year is poised to translate into more real-world uses in 2024 as potential applications of the technology expand to a broader market, according to Deutsche Bank analysts. “This [2024] is a pivotal year for generative AI to move beyond experimentation to implementation and for winners and losers to begin to emerge,” said Deutsche Bank research analysts Adrian Cox and Galina Pozdnyakova in a Monday client note. When gen ...

New Year has brought no cheer for Diageo with Deutsche Bank following up its ‘sell’ note of November with another brutal update reiterating the message. Deutsche Bank was a seller even before the Guinness, Johnnie Walker and Smirnoff group’s profit warning that month and its latest update suggests things have gotten worse since then. “Industry data and peer read across suggest that Spirits demand has continued to deteriorate following Diageo’s 10 November 2023 profit warning,” said the bank. As a consequenc ...

Deutsche Bank has reportedly resumed merger discussions with fellow German financial institution Commerzbank.The two companies had called off their initial plans to merge five years ago. But now, Reuters reported Monday (Jan. 15), uncertainty in the bank sector and Germany’s need to shore up its budget has renewed speculation about a tie-up.According to the report, Germany has said it is considering raising funds by selling stakes in some of its 100-plus state-owned companies, including its 15% share of Com ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value ...

GSK has received a healthy price target upgrade from analysts at Deutsche Bank, which has the UK pharma as a top pick in a sector with a mixed outlook in 2024. “Top-down, our sector view remains neutral and perhaps even more incrementally cautious for 2023 relative to FY23; however we do have a very clear rank order of preferences, with Novo, GSK and Novartis our buy recommendations.” AstraZeneca, Roche and Sanofi are its least preferred options. Deutsche Bank’s target price for GSK rises to 1,850p from 1,7 ...

Deutsche Bank upgraded JPMorgan Chase JPM, -0.15% to buy from hold while downgrading Wells Fargo WFC, to hold from buy, in a note on U.S. banks ahead of results this Friday. Analyst Matthew O’Connor said there are three key themes to 2024 — lower interest rates, which help bank capital but weigh on earnings; credit quality; and the regulatory and political backdrop. The price target on JPMorgan was lifted to $190 from $140, while the Wells Fargo target stayed at $51. Of the other big banks, Bank of America ...

In this articleMDLZKHCNES.N-CHULVR-GBA customer shops in a Kroger grocery store on July 15, 2022 in Houston, Texas.Brandon Bell | Getty ImagesInvestors have cheered a new class of weight loss drugs for their ability to help people shed unwanted pounds, but the findings of a recent poll underscore the challenges patients face if they cease treatment.The survey by Deutsche Bank found that calorie consumption declines when a patient takes a GLP-1 medication like Novo Nordisk's Ozempic or Wegovy. However, once ...

Strategists at Deutsche Bank downgraded European stocks to neutral Monday, citing “muted” upside for stocks over the coming weeks and uncertainty on major central banks’ monetary-policy outlook amid a shaky start to 2024 for the financial markets.“We expect markets to go mostly sideways with a mild setback of not more than 5% from current levels, predominantly in parts of the market that have seen the biggest inflows in the fourth quarter of last year,” said Deutsche Bank strategists led by Maximilian Uleer ...

Next PLC (LSE:NXT) has had its price target upgraded by Deutsche Bank following a stellar Christmas trading period as revealed on Thursday. Analysts at the German bank have kept the stock on its ‘hold’ rating but upgraded its share price target from 7,700p to 8,000p – just under a 5% decrease from the current 8,360p price. “Next has delivered its 5th profit upgrade for FY24e and topped this with an initial view of FY25e PBT that is c.1% ahead of consensus,” Deutsche Bank said. However, it remained cautious ...